» Articles » PMID: 15944446

Epidemiology of First-episode Psychosis: Illustrating the Challenges Across Diagnostic Boundaries Through the Cavan-Monaghan Study at 8 Years

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2005 Jun 10
PMID 15944446
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The epidemiology of first-episode psychosis is poorly understood because of the paucity of systematic studies, yet it constitutes the fundamental basis for understanding the disorder and the foundations on which clinical, biological, therapeutic, and long-term outcome studies are built. A particular need is to clarify the diagnostic breadth of first-episode psychosis and, on this basis, to undertake systematic comparisons across representative populations of the psychoses, to include comparisons with first-episode mania. Considered here is the new generation of prospective studies that may be able to inform in some way on these issues. Attainment of the above goals requires prolonged accrual of "all" cases of nonaffective, affective, and any other psychotic illness, including first-episode mania, to derive the required representative populations. To illustrate some of the challenges, the structure of the Cavan-Monaghan prospective first episode study is described and its interim findings are outlined, as rural Ireland provides psychiatric care based on strict catchment areas and is characterized by substantive ethnic and socioeconomic homogeneity and stability. It is argued that there are 3 primary diagnostic nodes (schizophrenia spectrum psychosis, bipolar disorder, and major depressive disorder with psychotic features) around which there exist numerous additional, overlapping, and well-populated diagnostic categories that are distinct only in terms of their operational definition. Only through systematic, epidemiologically based studies that access this intrinsic diversity are we likely to understand fully the origins and pathobiology of first-episode psychosis.

Citing Articles

Case identification and healthcare utilization in the years prior to a first mania diagnosis.

Benson N, Yang Z, Fung V, Smoller J, Ongur D, Hsu J J Affect Disord. 2024; 365:527-533.

PMID: 39182518 PMC: 11403575. DOI: 10.1016/j.jad.2024.08.117.


Patients with first-episode psychosis in northern Taiwan: neurocognitive performance and niacin response profile in comparison with schizophrenia patients of different familial loadings and relationship with clinical features.

Yu S, Hwang T, Liu C, Chan H, Kuo C, Yang T BMC Psychiatry. 2024; 24(1):155.

PMID: 38389072 PMC: 10885443. DOI: 10.1186/s12888-024-05598-2.


Prevalence and risk factors for psychotic symptoms in young, first-episode and drug-naïve patients with major depressive disorder.

Wu Y, Zhao X, Li Z, Yang R, Peng R, Zhou Y BMC Psychiatry. 2024; 24(1):66.

PMID: 38262974 PMC: 10807072. DOI: 10.1186/s12888-024-05517-5.


Effects of bipolar disorder on maternal and fetal health during pregnancy: a systematic review.

Mohamed M, Elhelbawy A, Khalid M, AbdAllatif L, Lialy H BMC Pregnancy Childbirth. 2023; 23(1):617.

PMID: 37641006 PMC: 10464164. DOI: 10.1186/s12884-023-05924-8.


The Importance of Cerebrospinal Fluid Investigation in First-episode Psychosis.

Paval D, Gherghel-Paval N, Capatina O, Stan A, Miclutia I, Gine-Serven E Yale J Biol Med. 2023; 96(1):125-126.

PMID: 37009189 PMC: 10052593. DOI: 10.59249/OAMT2710.